HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oral trimethoprim/sulfamethoxazole in the treatment of acne vulgaris.

Abstract
Oral trimethoprim/sulfamethoxazole (TMP-SMX) is approved by the US Food and Drug Administration for the treatment of urinary tract infections, shigellosis, acute otitis media in pediatric patients, and Pneumocystis carinii pneumonia. TMP-SMX has been used off label in dermatology to treat various skin conditions, including acne vulgaris and other skin and soft tissue infections, especially those infections caused by methicillin-resistant Staphylococcus aureus.
AuthorsSanjay Bhambri, James Q Del Rosso, Avani Desai
JournalCutis (Cutis) Vol. 79 Issue 6 Pg. 430-4 (Jun 2007) ISSN: 0011-4162 [Print] United States
PMID17713145 (Publication Type: Journal Article, Review)
Chemical References
  • Anti-Infective Agents
  • Trimethoprim, Sulfamethoxazole Drug Combination
Topics
  • Acne Vulgaris (drug therapy)
  • Anti-Infective Agents (adverse effects, therapeutic use)
  • Humans
  • Trimethoprim, Sulfamethoxazole Drug Combination (adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: